Literature DB >> 33623517

Mucinous urachal adenocarcinoma: A potential nonfluorodeoxyglucose-avid pitfall on 18fluorine-fluorodeoxyglucose positron emission tomography/computed tomography.

Jeeban Paul Das1,2, Hebert Alberto Vargas1,2, Gary A Ulaner1,2.   

Abstract

Mucinous adenocarcinoma of the urachal remnant is a nonurothelial malignancy that may be asymptomatic until locally advanced or metastatic. We describe a 37-year-old woman with invasive ductal breast carcinoma who underwent 18Fluorine-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) computed tomography (CT) demonstrating a non-FDG avid pelvic mass, initially suspected to represent a pedunculated uterine fibroid. Magnetic resonance imaging revealed a mixed solid-cystic mass separate from the uterus, suspicious for urachal neoplasm, confirmed as mucinous adenocarcinoma on histopathology. Urachal tumors may not be FDG-avid and represent a potential pitfall on FDG PET/CT. Copyright:
© 2020 World Journal of Nuclear Medicine.

Entities:  

Keywords:  18Fluorine-fluorodeoxyglucose; mucinous neoplasm; positron emission tomography/computed tomography; urachal adenocarcinoma

Year:  2020        PMID: 33623517      PMCID: PMC7875043          DOI: 10.4103/wjnm.WJNM_60_19

Source DB:  PubMed          Journal:  World J Nucl Med        ISSN: 1450-1147


  10 in total

Review 1.  Urachal remnant diseases: spectrum of CT and US findings.

Authors:  J S Yu; K W Kim; H J Lee; Y J Lee; C S Yoon; M J Kim
Journal:  Radiographics       Date:  2001 Mar-Apr       Impact factor: 5.333

2.  18FDG PET/CT findings in the unusual urachal adenocarcinoma.

Authors:  Marcos Duarte Guimarães; Almir Galvão Vieira Bitencourt; Eduardo Nóbrega Pereira Lima; Edson Marchiori
Journal:  Clin Nucl Med       Date:  2014-09       Impact factor: 7.794

3.  A Rare Case of Urachal Carcinoma Metastatic to Thoracic Vertebra Detected by FDG PET/CT.

Authors:  Guangjie Yang; Zhenguang Wang; Simin Liu; Fengyu Wu; Dacheng Li
Journal:  Clin Nucl Med       Date:  2017-07       Impact factor: 7.794

4.  FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features.

Authors:  K L Berger; S A Nicholson; F Dehdashti; B A Siegel
Journal:  AJR Am J Roentgenol       Date:  2000-04       Impact factor: 3.959

5.  Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy.

Authors:  Richard A Ashley; Brant A Inman; Thomas J Sebo; Bradley C Leibovich; Michael L Blute; Eugene D Kwon; Horst Zincke
Journal:  Cancer       Date:  2006-08-15       Impact factor: 6.860

Review 6.  Imaging of the Urachus: Anomalies, Complications, and Mimics.

Authors:  Carolina Parada Villavicencio; Sharon Z Adam; Paul Nikolaidis; Vahid Yaghmai; Frank H Miller
Journal:  Radiographics       Date:  2016 Nov-Dec       Impact factor: 5.333

7.  A rare case of urachal mucinous adenocarcinoma detected by 18F-FDG PET/CT.

Authors:  Xin Li; Songtao Liu; Shuzhan Yao; Muwen Wang
Journal:  Clin Nucl Med       Date:  2015-03       Impact factor: 7.794

Review 8.  FDG PET/CT Pitfalls in Gynecologic and Genitourinary Oncologic Imaging.

Authors:  Amish Lakhani; Sairah R Khan; Nishat Bharwani; Victoria Stewart; Andrea G Rockall; Sameer Khan; Tara D Barwick
Journal:  Radiographics       Date:  2017 Mar-Apr       Impact factor: 5.333

9.  Urachal carcinoma: a pathologic and clinical study of 46 cases.

Authors:  Jasreman Dhillon; Yu Liang; Ashish M Kamat; Arlene Siefker-Radtke; Colin P Dinney; Bogdan Czerniak; Charles C Guo
Journal:  Hum Pathol       Date:  2015-08-12       Impact factor: 3.466

10.  Urachal Carcinoma of the Bladder: Impact of Clinical and Immunohistochemical Parameters on Prognosis.

Authors:  Christian Niedworok; Martin Panitz; Tibor Szarvas; Henning Reis; Anna Carinna Reis; Attila Szendröi; Peter Nyirády; A Marcell Szasz; Orsolya Módos; Herbert Rübben; Frank Vom Dorp
Journal:  J Urol       Date:  2015-12-08       Impact factor: 7.450

  10 in total
  1 in total

1.  Clinical Utility of 18F-FDG PET/CT for Staging and Treatment Planning in Urachal Adenocarcinoma.

Authors:  Jeeban P Das; Hebert A Vargas; Soleen Ghafoor; Alvin C Goh; Gary A Ulaner
Journal:  J Nucl Med       Date:  2020-09-18       Impact factor: 10.057

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.